Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

AML - 424

Dual Targeting of FLT3 Signaling and BCL2 Dependency by Venetoclax in ATO-Resistant FLT3-ITD Acute Promyelocytic Leukemia

Deepshikha Dutta

Poster Presenter: Deepshikha Dutta

Thumbnail for Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

AML - 454

Persistent DNMT3A Mutations Predicting Relapse After Acute Myeloid Leukemia Remission: A Systematic Review of Molecular Persistence and Circulating DNA Dynamics

Sahar Amjad

Poster Presenter: Sahar Amjad

Previous 1...35 36 37 38 39 40 41...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Long-term follow-up of Oral Decitabine/Cedazuridine (ASTX727) Plus Venetoclax in Older or Unfit patients with Newly Diagnosed Acute Myeloid Leukemia

AML - 460

Long-term follow-up of Oral Decitabine/Cedazuridine (ASTX727) Plus Venetoclax in Older or Unfit patients with Newly Diagnosed Acute Myeloid Leukemia

Thura Win Htut

Poster Presenter: Thura Win Htut

Thumbnail for Induction Regimens and Responses in Acute Myeloid Leukemia: Data From a Low- and Middle-Income Country

AML - 464

Induction Regimens and Responses in Acute Myeloid Leukemia: Data From a Low- and Middle-Income Country

Zaigam Ismail

Poster Presenter: Zaigam Ismail

Thumbnail for DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

AML - 468

DNMT3A Co-Mutation and Immune Exclusion Signatures Define Outcomes in AML With IDH2 Mutations

Feng-Ming Tien

Poster Presenter: Feng-Ming Tien

Thumbnail for PEARL Score and Single-Cell Transcriptomic Profiling Reveal Clinical and Molecular Determinants of Early Death in Acute Promyelocytic Leukemia

AML - 473

PEARL Score and Single-Cell Transcriptomic Profiling Reveal Clinical and Molecular Determinants of Early Death in Acute Promyelocytic Leukemia

Akash Maity

Poster Presenter: Akash Maity

Thumbnail for The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

AML - 477

The Efficacy of Pivekimab Sunirine (PVEK) in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm With Baseline Skin Involvement in the CADENZA Study

Naveen Pemmaraju

Poster Presenter: Naveen Pemmaraju

Thumbnail for Clinical Outcomes of Induction Chemotherapy During Mechanical Ventilation in Newly Diagnosed Acute Myeloid Leukemia

AML - 495

Clinical Outcomes of Induction Chemotherapy During Mechanical Ventilation in Newly Diagnosed Acute Myeloid Leukemia

Benjamin McCormick

Poster Presenter: Benjamin McCormick

Thumbnail for Favorable Outcomes Including Post-Transplant Survival Are Seen Independent of Baseline Skin Burden in Treatment-Naοve Patients (Pts) With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated With Tagraxofusp (TAG): Subgroup Analysis of a Pivotal Trial

AML - 498

Favorable Outcomes Including Post-Transplant Survival Are Seen Independent of Baseline Skin Burden in Treatment-Naοve Patients (Pts) With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Treated With Tagraxofusp (TAG): Subgroup Analysis of a Pivotal Trial

Eunice S Wang

Poster Presenter: Eunice S Wang

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors